Functional Angioplasty: Definitions, Historical Overview, and Future Perspectives

다국어 초록 (Multilingual Abstract)

Percutaneous coronary intervention (PCI) is used to treat obstructive coronary artery disease (CAD). The role of PCI is well defined in acute coronary syndrome, but that for stable CAD remains debatable. Although PCI generally relieves angina in patients with stable CAD, it may not change its prognosis. The extent and severity of CAD are major determinants of prognosis, and complete revascularization (CR) of all ischemia-causing lesions might improve outcomes. Several studies have shown better outcomes with CR than with incomplete revascularization, emphasizing the importance of functional angioplasty. However, different definitions of inducible myocardial ischemia have been used across studies, making their comparison difficult. Various diagnostic tools have been used to estimate the presence, extent, and severity of inducible myocardial ischemia. However, to date, there are no agreed reference standards of inducible myocardial ischemia. The hallmarks of inducible myocardial ischemia such as electrocardiographic changes and regional wall motion abnormalities may be more clinically relevant as the reference standard to define ischemia-causing lesions. In this review, we summarize studies regarding myocardial ischemia, PCI guidance, and possible explanations for similar findings across studies. Also, we provide some insights into the ideal definition of inducible myocardial ischemia and highlight the appropriate PCI strategy.

참고문헌 (Reference)

1 Detre K, "Veterans administration cooperative study of surgery for coronary arterial occlusive disease. III. Methods and baseline characteristics, including experience with medical treatment" 40 : 212-225, 1977

2 Timmis A, "Validity of inducible ischaemia as a surrogate for adverse outcomes in stable coronary artery disease" 104 : 1733-1738, 2018

3 Davies JE, "Use of the instantaneous wave-free ratio or fractional flow reserve in PCI" 376 : 1824-1834, 2017

4 Varnauskas E, "Twelve-year follow-up of survival in the randomized European Coronary Surgery Study" 319 : 332-337, 1988

5 Novack V, "Troponin criteria for myocardial infarction after percutaneous coronary intervention" 172 : 502-508, 2012

6 Kobayashi Y, "The prognostic value of residual coronary stenoses after functionally complete revascularization" 67 : 1701-1711, 2016

7 Nesto RW, "The ischemic cascade : temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia" 59 : 23-, 1987

8 Mann FC, "The effect on the blood flow of decreasing the lumen of a blood vessel" 4 : 249-252, 1938

9 Chaitman BR, "The bypass angioplasty revascularization investigation 2diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease : impact of treatment strategy on cardiac mortality and myocardial infarction" 120 : 2529-2540, 2009

10 King SB 3rd, "Ten-year completed follow-up of percutaneous transluminal coronary angioplasty : the early Zurich experience" 22 : 353-360, 1993

11 Taglieri N, "Target lesion failure with current drug-eluting stents : evidence from a comprehensive network meta-analysis" 13 : 2868-2878, 2020

12 Morice MC, "Sirolimus-vs paclitaxel-eluting stents in de novo coronary artery lesions : the REALITY trial : a randomized controlled trial" 295 : 895-904, 2006

13 Deedwania PC, "Silent myocardial ischemia. A clinical perspective" 151 : 2373-2382, 1991

14 Henderson RA, "Seven-year outcome in the RITA-2 trial : coronary angioplasty versus medical therapy" 42 : 1161-1170, 2003

15 Proudfit WL, "Selective cine coronary arteriography. Correlation with clinical findings in 1, 000 patients" 33 : 901-910, 1966

16 Bangalore S, "Routine revascularization versus initial medical therapy for stable ischemic heart disease : a systematic review and meta-analysis of randomized trials" 142 : 841-857, 2020

17 Stone GW, "Relationship between infarct size and outcomes following primary PCI : patient-level analysis from 10 randomized trials" 67 : 1674-1683, 2016

18 Uren NG, "Relation between myocardial blood flow and the severity of coronary-artery stenosis" 330 : 1782-1788, 1994

19 Smalling RW, "Regional myocardial function is not affected by severe coronary depressurization provided coronary blood flow is maintained" 5 : 948-955, 1985

20 "RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial" 350 : 461-468, 1997

21 Danad I, "Quantitative assessment of myocardial perfusion in the detection of significant coronary artery disease : cutoffvalues and diagnostic accuracy of quantitative [15O]H2O PET imaging" 64 : 1464-1475, 2014

22 Farooq V, "Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery(SYNTAX)trial validation of the residual SYNTAX score" 128 : 141-151, 2013

23 Bittencourt MS, "Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events" 7 : 282-291, 2014

24 Prasad A, "Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes : an analysis from the ACUITY(Acute Catheterization and Urgent Intervention Triage Strategy)trial" 54 : 477-486, 2009

25 Bangalore S, "Prognostic implications of procedural vs spontaneous myocardial infarction : results from the Evaluation of Drug Eluting Stents and Ischemic Events(EVENT)registry" 166 : 1027-1034, 2013

26 Choi KH, "Prognostic implication of functional incomplete revascularization and residual functional SYNTAX score in patients with coronary artery disease" 11 : 237-245, 2018

27 Silvain J, "Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI : a pooled analysis of patient-level data" 42 : 323-334, 2021

28 Mancini GBJ, "Predicting outcome in the COURAGE trial(Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) : coronary anatomy versus ischemia" 7 : 195-201, 2014

29 Billinger M, "Physiologically assessed coronary collateral flow and adverse cardiac ischemic events : a follow-up study in 403 patients with coronary artery disease" 40 : 1545-1550, 2002

30 Bugiardini R, "Persisting chest pain in nonobstructive coronary artery disease" 2 : 69-71, 2016

31 Al-Lamee R, "Percutaneous coronary intervention in stable angina(ORBITA) : a double-blind, randomised controlled trial" 391 : 31-40, 2018

32 Øhrn AM, "Pain tolerance in persons with recognized and unrecognized myocardial infarction : a population-based, cross-sectional study" 5 : e003846-, 2016

33 Shaw LJ, "Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden : results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation(COURAGE)trial nuclear substudy" 117 : 1283-1291, 2008

34 Boden WE, "Optimal medical therapy with or without PCI for stable coronary disease" 356 : 1503-1516, 2007

35 Grüntzig AR, "Nonoperative dilatation of coronary-artery stenosis : percutaneous transluminal coronary angioplasty" 301 : 61-68, 1979

36 Hearse DJ, "Myocardial ischaemia : can we agree on a definition for the 21st century?" 28 : 1737-1744, 1994

37 Morice MC, "Long-term clinical outcomes with sirolimus-eluting coronary stents : five-year results of the RAVEL trial" 50 : 1299-1304, 2007

38 Saraiva RM, "Left atrial structure and function predictors of new-onset atrial fibrillation in patients with chagas disease" 33 : 1363-1374, 2020

39 Fox K, "Ivabradine in stable coronary artery disease without clinical heart failure" 371 : 1091-1099, 2014

40 Johnson NP, "Is discordance of coronary flow reserve and fractional flow reserve due to methodology or clinically relevant coronary pathophysiology?" 5 : 193-202, 2012

41 Lee JM, "Integrated myocardial perfusion imaging diagnostics improve detection of functionally significant coronary artery stenosis by 13N-ammonia positron emission tomography" 9 : e004768-, 2016

42 Götberg M, "Instantaneous wave-free ratio versus fractional flow reserve to guide PCI" 376 : 1813-1823, 2017

43 Maron DJ, "Initial invasive or conservative strategy for stable coronary disease" 382 : 1395-1407, 2020

44 Habib GB, "Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction(TIMI)trial" 83 : 739-746, 1991

45 Warren J, "Incidence and impact of totally occluded culprit coronary arteries in patients presenting with non-ST-segment elevation myocardial infarction" 115 : 428-433, 2015

46 Gregson J, "Implications of alternative definitions of peri-procedural myocardial infarction after coronary revascularization" 76 : 1609-1621, 2020

47 Mortensen MB, "Impact of plaque burden versus stenosis on ischemic events in patients with coronary atherosclerosis" 76 : 2803-2813, 2020

48 May AG, "Hemodynamic effects of arterial stenosis" 53 : 513-524, 1963

49 Spertus JA, "Health-status outcomes with invasive or conservative care in coronary disease" 382 : 1408-1419, 2020

50 De Bruyne B, "Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease" 367 : 991-1001, 2012

51 de Waard GA, "Fractional flow reserve, instantaneous wave-free ratio, and resting Pd/Pa compared with [15O]H2O positron emission tomography myocardial perfusion imaging : a PACIFIC trial sub-study" 39 : 4072-4081, 2018

52 Tonino PA, "Fractional flow reserve versus angiography for guiding percutaneous coronary intervention" 360 : 213-224, 2009

53 van Nunen LX, "Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease(FAME) : 5-year follow-up of a randomised controlled trial" 386 : 1853-1860, 2015

54 Xaplanteris P, "Five-year outcomes with PCI guided by fractional flow reserve" 379 : 250-259, 2018

55 Savage MP, "Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries" 31 : 307-311, 1998

56 Morrow DA, "Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes : the MERLIN-TIMI 36randomized trial" 297 : 1775-1783, 2007

57 Gould KL, "Effects of coronary stenoses on coronary flow reserve and resistance" 34 : 48-55, 1974

58 IONA Study Group, "Effect of nicorandil on coronary events in patients with stable angina : the Impact Of Nicorandil in Angina(IONA)randomised trial" 359 : 1269-1275, 2002

59 Al-Lamee RK, "Dobutamine stress echocardiography ischemia as a predictor of the placebo-controlled efficacy of percutaneous coronary intervention in stable coronary artery disease : the stress echocardiography-stratified analysis of ORBITA" 140 : 1971-1980, 2019

60 de Marchi SF, "Determinants of human coronary collaterals" 10 : 24-28, 2014

61 Nelson AJ, "Current approach to the diagnosis of atherosclerotic coronary artery disease : more questions than answers" 10 : 2040622319884819-, 2019

62 Canty JM Jr, "Coronary pressure-function and steady-state pressure-flow relations during autoregulation in the unanesthetized dog" 63 : 821-836, 1988

63 Di Gioia G, "Coronary autoregulatory plateau in humans" 76 : 1270-1271, 2020

64 "Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data" 68 : 939-950, 1983

65 Gaba P, "Complete versus incomplete coronary revascularization : definitions, assessment and outcomes" 18 : 155-168, 2021

66 Ahn JM, "Comparison of stenting versus bypass surgery according to the completeness of revascularization in severe coronary artery disease : patient-level pooled analysis of the SYNTAX, PRECOMBAT, and BEST trials" 10 : 1415-1424, 2017

67 O’Fee K, "Association of inducible myocardial ischemia with long-term mortality and benefit from coronary artery bypass graft surgery in ischemic cardiomyopathy : ten-year follow-up of the STICH trial" 143 : 205-207, 2021

68 Brener SJ, "Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality" 40 : 1961-1967, 2002

69 Nakagomi A, "Angiographic severity of coronary narrowing is a surrogate marker for the extent of coronary atherosclerosis" 78 : 516-519, 1996

70 Gould KL, "Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making" 62 : 1639-1653, 2013

71 Loop FD, "An 11 year evolution of coronary arterial surgery(1968-1978)" 190 : 444-455, 1979

72 Patel MR, "ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease : a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons" 69 : 2212-2241, 2017

73 Fischman DL, "A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease" 331 : 496-501, 1994

74 Knuuti J, "2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes" 41 : 407-477, 2020

75 Neumann FJ, "2018 ESC/EACTS guidelines on myocardial revascularization" 40 : 87-165, 2019

76 Fihn SD, "2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons" 64 : 1929-1949, 2014